Cold Chain Logistics for Healthcare: Emerging Opportunities in Cell Therapies, Vaccines and Human

Presently, a wide variety of pharmaceutical products, such as biologics, vaccines, human organs for transplantation and certain conventional pharmacological interventions as well, are temperature sensitive and require freezing / cryogenic holding temperatures. In fact, over 95% of all approved biologics and 90% of all vaccines are cold chain dependent. Stakeholders in this segment have designed and established a variety of innovative solutions to serve the evolving demands. Given the recent technical breakthroughs and advances, and the steadily rising demand for biopharmaceuticals, the reliance on cold chain is expected to increase substantially, causing logistics service providers to contemplate, devise and implement flexible business strategies and operational models to cope up with the future needs.

Leave a Reply

Your email address will not be published. Required fields are marked *